Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (959)
All Articles published online
|
Publishing Process of This Article
|
Dec 24, 2025 (publication date) through May 20, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Meng LL, Di YP, Ma L, Qu BL. Advances in prostate cancer treatment with moderate and ultra-hypofractionated radiotherapy. World J Clin Oncol 2025; 16(12): 112735 [PMID: 41480171 DOI: 10.5306/wjco.v16.i12.112735] |
|
|
|
| All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply. | |
| For: | Meng LL, Di YP, Ma L, Qu BL. Advances in prostate cancer treatment with moderate and ultra-hypofractionated radiotherapy. World J Clin Oncol 2025; 16(12): 112735 [PMID: 41480171 DOI: 10.5306/wjco.v16.i12.112735] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v16/i12/112735.htm |
| Number | Citing Articles |
| 1 |
Nada Samir Shams El-Din El-Behiri, Mohamed A Alm El-Din, Asmaa Mohamed Alkady, Rabab Mahmoud Moussa, Mohamed Mohamed Elshebeny. Hypofractionated versus conventional IMRT in unfavorable intermediate- and high-risk prostate cancer: A phase II comparative study of PSA kinetics, dosimetric and toxicity outcomes. The French Journal of Urology 2026; 36(5): 103104 doi: 10.1016/j.fjurol.2026.103104
|